EyeGene Inc.

Informe acción KOSDAQ:A185490

Capitalización de mercado: ₩77.3b

EyeGene Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Won-Il Yoo

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO24.4yrs
Participación del CEO4.8%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates

Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Jul 26
Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

Mar 29
Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Feb 01
EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

Dec 07
Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

CEO

Won-Il Yoo

24.4yrs

Permanencia

Mr. Won-Il Yoo has been Chief Executive Officer of EyeGene, Inc. since June 2000. Mr. Yoo has directed EyeGene's initial financing, set-up, recruiting, R&D and business development. He has over 12 years re...